Barrow Clinical Trial Evaluating Gene Therapy for Familial ALS
Barrow Neurological Institute is one of 17 centers worldwide participating in a clinical trial that will evaluate a gene therapy for the inherited form of amyotrophic lateral sclerosis (ALS) caused by a mutation on the…
‘ALS AT HOME’ Study Allows People to Participate Remotely
A new ALS study at Barrow Neurological Institute that allows people to participate remotely could change the way clinical trials for this disease are performed. ALS Testing Through Home-Based Outcome Measures, or ALS AT HOME,…
Barrow Intern Featured in Arizona Republic Story About Women in STEM
Nancy Twishime, a high school intern in Dr. Rita Sattler’s laboratory at Barrow, was featured in a story in The Arizona Republic about women in STEM. Twishime, 17, joined Dr. Sattler’s lab as part of Barrow’s…
ALS Association Recognizes Discovery by Barrow, IBM Watson Health
In its top 10 list of advances in ALS research in 2016, the ALS Association recognized a discovery made by Barrow Neurological Institute and IBM Watson Health. IBM Watson became known around the nation in 2011 when it…
